The discussion highlights a recognition of the study's value with phrases like 'Worth a read,' but also emphasizes a lingering concern about limited funding for groundbreaking research in biopharma, indicating a cautious interest and moderate agreement. The tone suggests familiarity with the subject and a critical perspective on industry progress, aligning with neutral engagement and impact levels.
AgreementModerate agreement
The post shows moderate agreement, acknowledging the importance of the publication but expressing skepticism about the level of innovation in the industry.
InterestModerate interest
The discussion indicates some interest in the topic, but it’s somewhat limited to a general awareness rather than deep enthusiasm.
EngagementNeutral engagement
The post is brief and does not delve into detailed analysis or discussion, reflecting a neutral level of engagement.
ImpactNeutral impact
The reaction suggests the publication's content is somewhat impactful but not transformative, largely reaffirming existing views on industry innovation and funding.
Abstract in brief
This study evaluates the use of process analytical technologies (PAT) in biologics manufacturing, focusing on their technical benefits like process understanding and control, as well as their business advantages such as ease of implementation and cost savings.
Through an industry survey, the research identified high-value PAT tools like online liquid chromatography, inline Raman spectroscopy, and gas analysis during upstream processing, along with UV-Vis, light scattering, and automated sampling in downstream steps.
The insights aim to guide both current practitioners and newcomers in selecting and applying PAT tools effectively, enhancing the efficiency and quality of biotherapeutic development and production.]
Worth a read, but feel like industry Biopharma PD is not given sufficient blue sky research funding to change to paradigm of "next gen manufacturing", a little bit same old, same old...
Systematic assessment of process analytical technologies for biologics
https://t.co/jJEBCtgYnT
This study evaluates the use of process analytical technologies in biologics manufacturing, focusing on their benefits for process understanding, control, and cost savings. Insights guide effective application of PAT…
This video explores how low-temperature culture and genetic engineering of mTORC1 signaling pathways enhance recombinant protein production in CHO cells, a key method for biopharmaceutical manufacturing.
Worth a read, but feel like industry Biopharma PD is not given sufficient blue sky research funding to change to paradigm of "next gen manufacturing", a little bit same old, same old...
Systematic assessment of process analytical technologies for biologics
https://t.co/jJEBCtgYnT
Previewpdf | PDF | Chemical Reactor | Organic Synthesis
News
doi:10.1002/bit.27990. Goby JD , Khouri JN , Durve A , Zimmerman E , Furuya K . Control of protein a column loading during continuous antibody production: ...
Canby Et Al. (2020) | PDF | Mindfulness | Meditation
News
... bit of a barrier to maybe making friends.” Other participants said to each ... doi: 10.1002/jclp. Hjeltnes, A., Binder, P. E., Moltu, C., and Dundas, I ...
Positive Psychology and Mindfulness | PDF | Positive Psychology ...
News
Health Well Being 10: 27990. doi: Bandura, A. (1997). Self-efficacy: The ... doi: 10.1002/pits.20149. Research. Master Sheng Yen. (2010). The Dharma ...
(Health Informatics) Connie W. Delaney, Charlotte A. Weaver, Judith ...
News
bit of fun with data and technology) (b) 50th Anniversary of Moore's Law ... 10.1002/aris.1440380113. Kranzberg M. Technology and history: Kransberg's ...
BookofProceedings ICOPEV2014 | PDF | Innovation | New Product ...
News
... 27990 produce 3.0 kW of electricity and 10.5 kW of thermal Hinnells, M ... 10.1002/bse Waste Management is always considering the. Porter, M. E. (1991) ...